Search bioRxiv⌕ Search

bioRxiv · 10.1101/2022.07.11.499534

Genetic mapping of some key plant architecture traits in Brassica juncea using a cross between two distinct lines - vegetable type Tumida and oleiferous Varuna

Abstract

Brassica juncea (AABB, 2n=36), commonly called mustard is an allopolyploid crop of recent origin but has considerable morphological and underlying genetic variation. An F1-derived doubled haploid (F1DH) population developed from a cross between a Indian oleiferous line, Varuna, and a Chinese stem type vegetable mustard, Tumida showed significant variability for some key plant architectural traits, including four stem strength-related traits, stem diameter, plant height, branch initiation height, number of primary branches (Pbr), and days to flowering (Df). Multi-environment QTL analysis identified twenty environmentally stable QTL for the nine plant architectural traits. Both Tumida and Varuna contain some positive QTL that can be used to breed superior ideotypes in mustard. A QTL cluster on LG A10 contained environmentally stable QTL for seven architectural traits. This region also contained overlapping environmentally stable major QTL (phenotypic variance [≥] 10%) for Df and Pbr, with Tumida contributing the trait enhancing alleles for both the traits. Since early flowering is critical for the cultivation of mustard in the Indian subcontinent, this QTL cannot be used for the improvement of Pbr in the Indian gene pool lines. Conditional QTL analysis for Pbr identified the QTL for improvement of Pbr without negative effects on Df. The environmentally stable QTL were projected on the genome assemblies of Tumida and Varuna for the identification of candidate genes. These findings provide insights into the genetics of plant architectural traits in two diverse gene pools of B. juncea and provide opportunities for improvement of the plant architecture through marker-assisted introgressions. Key MessageGenetic mapping of some key plant architectural traits in a vegetable type and an oleiferous B. juncea cross revealed environmentally stable QTL and candidate genes for breeding more productive ideotypes.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

MATHUR, S., SINGH, P., YADAVA, S. K., GUPTA, V., PRADHAN, A. K., PENTAL, D.. 2022-07-12. Genetic mapping of some key plant architecture traits in Brassica juncea using a cross between two distinct lines - vegetable type Tumida and oleiferous Varuna. https://doi.org/10.1101/2022.07.11.499534

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

OPA1 controls mitochondrial dysfunction-driven liver fibrosis in MASLD

Progressive hepatic fibrosis is the principal determinant of morbidity and mortality in metabolic dysfunction-associated steatotic liver disease and steatohepatitis (MASLD/MASH). Mitochondrial dysfunction is a hallmark of MASH, and the release of mitochondrial damage-associated molecular patterns (mito-DAMPs) from injured hepatocytes can promote fibrosis. However, how mitochondrial dynamics and quality control shape the fibrotic response in MASLD/MASH remains unclear. Here, through large-scale genomic analyses of mitochondrial genes governing mitophagy, fusion and fission in human MASLD, with a power-equivalent sample size of approximately 700,000 individuals, we identify a strong association between hepatic fibrosis and the mitochondrial fusion factor dynamin-like GTPase optic atrophy 1 (OPA1). OPA1 transcripts and protein abundance in the liver epithelium were progressively dysregulated with advancing fibrosis. In mice, hepatocyte-specific OPA1 loss alone was sufficient to induce hepatic stellate cell activation and fibrosis in zone 3, promoted the release of mito-DAMPs into the circulation and exacerbated fibrosis in experimental MASH. These findings identify OPA1 as a central regulator of the hepatic fibrotic response and connect defective mitochondrial homeostasis to mito-DAMP release, hepatic stellate cell activation and fibrosis in MASLD.

genetics↗

Temporal control of mitochondrial mutagenesis reveals the fate of mtDNA mutations with age

Mutations in the mitochondrial genome (mtDNA) play a critical role in the aging process and a wide variety of age-related diseases. However, it remains unclear when the mutations that drive physiological decline arise. To answer this question, we generated a new mouse model in which mitochondrial mutagenesis can be confined to a defined window of time. Surprisingly, we found that mutations that arise during the first two months of life are sufficient to drive a wide variety of age-related pathologies, and that the severity of this pathology is broadly regulated by distinct, tissue-specific selective pressures that control the fate of mtDNA mutations with age. Further, we found that selection against deleterious variants can be modulated by manipulation of mitochondrial fusion in vitro and in vivo. These observations raise the possibility that in some tissues, the pace of aging is pre-determined by events that occur early in life and that interventions targeting mitochondrial fusion may be able to slow down or reverse the expansion of these pathogenic variants. These results carry far-reaching implications for strategies aimed at preventing or delaying age-related decline.

genetics↗

Innate immune stress pathway activation underlies heterochromatin dysfunction pathology

Heterochromatin loss disrupts nuclear architecture, gene regulation and repetitive element silencing, and is associated with diverse human diseases. However, mechanisms linking heterochromatin dysfunction to pathological phenotypes remain unclear. Using genetic interaction screening and genomic analyses in C. elegans, we identify secondary activation of the Intracellular Pathogen Response (IPR), an innate immune stress pathway, as a major contributor to heterochromatin mutant phenotypes. Constitutive IPR activation phenocopies slow growth and indirect transcriptional changes observed in these mutants. Depletion of genetic enhancers further increased, whereas suppressor RNAi attenuated IPR activation, with direct heterochromatin targets remaining substantially deregulated. Notably, many suppressors encode active chromatin components, and mild reduction of RNA polymerase II activity ameliorates growth defects in C. elegans HP1 mutants and human HP1-deficient cells. Our findings reveal secondary stress response activation as an important mechanism linking heterochromatin dysfunction to pathology and identify transcriptional dampening as a potential therapeutic strategy for mitigating these effects.

genetics↗